These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9278891)

  • 1. Pharmacokinetics and pharmacodynamics of a sustained-release biodegradable pellet containing imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Tagawa K; Murata K; Banno K; Sato T
    J Pharm Biomed Anal; 1997 Aug; 15(12):1861-6. PubMed ID: 9278891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Biomed Anal; 1997 Aug; 15(12):1851-9. PubMed ID: 9278890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats.
    Sasaki Y; Noguchi T; Seki J; Giddings JC; Yamamoto J
    Thromb Haemost; 2000 May; 83(5):722-7. PubMed ID: 10823269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
    Hosoya K; Ishimitsu T
    Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril.
    Tsuruoka S; Kitoh Y; Kawaguchi A; Sugimoto K; Hayasaka T; Saito T; Fujimura A
    J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats.
    Wang JM; Wang Y; Zhu ZS; Zhang MC; Zou Y; Li JJ; Li MJ; Jiang XJ; Li XY
    Life Sci; 2004 Jun; 75(4):407-20. PubMed ID: 15147828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration.
    Kohno I; Ijiri H; Takusagawa M; Yin DF; Sano S; Ishihara T; Sawanobori T; Komori S; Tamura K
    Chronobiol Int; 2000 Mar; 17(2):209-19. PubMed ID: 10757465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure.
    Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
    Eur J Clin Pharmacol; 1998 Mar; 54(1):59-61. PubMed ID: 9591932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide release from kidneys of hypertensive rats treated with imidapril.
    Hirata Y; Hayakawa H; Kakoki M; Tojo A; Suzuki E; Kimura K; Goto A; Kikuchi K; Nagano T; Hirobe M; Omata M
    Hypertension; 1996 Mar; 27(3 Pt 2):672-8. PubMed ID: 8613223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
    Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
    J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].
    Hashimoto Y; Kubo M; Sugaya T; Minobe S; Watanabe T; Yamamura M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):51-61. PubMed ID: 8076891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function.
    Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
    Eur J Clin Pharmacol; 1997; 51(6):489-91. PubMed ID: 9112065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human.
    Tagawa K; Mizobe M; Noda K
    Biol Pharm Bull; 1995 Jan; 18(1):64-9. PubMed ID: 7735253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of an angiotensin-converting-enzyme inhibitor, imidapril, and Ca2+ channel antagonist, amlodipine, in spontaneously hypertensive rats at established stage of hypertension.
    Yokota S; Naito Y; Yoshida H; Ohara N; Adachi T; Narita H
    Jpn J Pharmacol; 1998 May; 77(1):79-87. PubMed ID: 9639063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of imidapril on cerebral lesions observed by magnetic resonance imaging in malignant stroke-prone spontaneously hypertensive rats.
    Takahashi M; Fritz-Zieroth B; Ohta Y; Chikugo T
    J Hypertens; 1994 Jul; 12(7):761-8. PubMed ID: 7963504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
    Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
    J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats.
    Tomita N; Yamasaki K; Izawa K; Kunugiza Y; Osako MK; Ogihara T; Morishita R
    Int J Mol Med; 2007 Apr; 19(4):571-9. PubMed ID: 17334632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype.
    Ohmichi N; Iwai N; Uchida Y; Shichiri G; Nakamura Y; Kinoshita M
    Am J Hypertens; 1997 Aug; 10(8):951-5. PubMed ID: 9270093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.